Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 1
1969 1
1970 2
1972 1
1973 1
1974 1
1975 1
1976 1
1977 6
1978 5
1979 3
1980 2
1981 1
1982 5
1983 2
1984 1
1985 3
1986 3
1987 2
1988 5
1989 7
1990 6
1991 2
1992 9
1993 10
1994 11
1995 10
1996 5
1997 6
1998 10
1999 18
2000 23
2001 19
2002 18
2003 18
2004 14
2005 13
2006 17
2007 24
2008 18
2009 21
2010 14
2011 12
2012 9
2013 10
2014 13
2015 19
2016 11
2017 11
2018 13
2019 11
2020 16
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

449 results
Results by year
Filters applied: . Clear all
Page 1
TAS-102 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE): an investigator-initiated, open-label, single-arm, multicentre, phase 1/2 study.
Kuboki Y, Nishina T, Shinozaki E, Yamazaki K, Shitara K, Okamoto W, Kajiwara T, Matsumoto T, Tsushima T, Mochizuki N, Nomura S, Doi T, Sato A, Ohtsu A, Yoshino T. Kuboki Y, et al. Among authors: kajiwara t. Lancet Oncol. 2017 Sep;18(9):1172-1181. doi: 10.1016/S1470-2045(17)30425-4. Epub 2017 Jul 28. Lancet Oncol. 2017. PMID: 28760399 Clinical Trial.
Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study.
Moriwaki T, Fukuoka S, Taniguchi H, Takashima A, Kumekawa Y, Kajiwara T, Yamazaki K, Esaki T, Makiyama C, Denda T, Satake H, Suto T, Sugimoto N, Enomoto M, Ishikawa T, Kashiwada T, Sugiyama M, Komatsu Y, Okuyama H, Baba E, Sakai D, Watanabe T, Tamura T, Yamashita K, Gosho M, Shimada Y. Moriwaki T, et al. Among authors: kajiwara t. Oncologist. 2018 Jan;23(1):7-15. doi: 10.1634/theoncologist.2017-0275. Epub 2017 Sep 11. Oncologist. 2018. PMID: 28894015 Free PMC article.
Multicenter Phase I/II Study of Nivolumab Combined with Paclitaxel Plus Ramucirumab as Second-line Treatment in Patients with Advanced Gastric Cancer.
Nakajima TE, Kadowaki S, Minashi K, Nishina T, Yamanaka T, Hayashi Y, Izawa N, Muro K, Hironaka S, Kajiwara T, Kawakami Y. Nakajima TE, et al. Among authors: kajiwara t. Clin Cancer Res. 2021 Feb 15;27(4):1029-1036. doi: 10.1158/1078-0432.CCR-20-3559. Epub 2020 Dec 1. Clin Cancer Res. 2021. PMID: 33262133 Free article.
[A Case of Sigmoid Colon Cancer with Thrombotic Microangiopathy].
Sato K, Karasawa H, Kajiwara T, Suzuki H, Kohyama A, Watanabe K, Ohnuma S, Kamei T, Unno M. Sato K, et al. Among authors: kajiwara t. Gan To Kagaku Ryoho. 2020 Dec;47(13):2358-2360. Gan To Kagaku Ryoho. 2020. PMID: 33468960 Japanese.
449 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page